Clinical trials
Fabry Disease trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Terminated | 6 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amicus Therapeutics | 7 |
| Genzyme, a Sanofi Company | 6 |
| University Hospital, Bordeaux | 5 |
| CENTOGENE GmbH Rostock | 3 |
| Amicus Therapeutics France SAS | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Chiesi Farmaceutici S.p.A. | 2 |
| Hospices Civils de Lyon | 2 |
| Sanofi | 2 |
| Centre Hospitalier Universitaire de Nice | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fabry Disease | 42 |
| Stroke | 3 |
| Chronic Pain | 2 |
| Kidney Failure, Chronic | 2 |
| Proteinuria | 2 |
| Angiokeratoma | 1 |
| Cardiomyopathies | 1 |
| Diabetic Nephropathies | 1 |
| Hypertrophy, Left Ventricular | 1 |
| Ischemic Stroke | 1 |
Trials
Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.